Cargando…
Enhancement of chemotherapy by manipulation of tumour pH
The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363059/ https://www.ncbi.nlm.nih.gov/pubmed/10362108 http://dx.doi.org/10.1038/sj.bjc.6690455 |
_version_ | 1782153609554690048 |
---|---|
author | Raghunand, N He, X Sluis, R van Mahoney, B Baggett, B Taylor, C W Paine-Murrieta, G Roe, D Bhujwalla, Z M Gillies, R J |
author_facet | Raghunand, N He, X Sluis, R van Mahoney, B Baggett, B Taylor, C W Paine-Murrieta, G Roe, D Bhujwalla, Z M Gillies, R J |
author_sort | Raghunand, N |
collection | PubMed |
description | The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological’ resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore (31)P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon. © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2363059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23630592009-09-10 Enhancement of chemotherapy by manipulation of tumour pH Raghunand, N He, X Sluis, R van Mahoney, B Baggett, B Taylor, C W Paine-Murrieta, G Roe, D Bhujwalla, Z M Gillies, R J Br J Cancer Regular Article The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological’ resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore (31)P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon. © 1999 Cancer Research Campaign Nature Publishing Group 1999-06 /pmc/articles/PMC2363059/ /pubmed/10362108 http://dx.doi.org/10.1038/sj.bjc.6690455 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Raghunand, N He, X Sluis, R van Mahoney, B Baggett, B Taylor, C W Paine-Murrieta, G Roe, D Bhujwalla, Z M Gillies, R J Enhancement of chemotherapy by manipulation of tumour pH |
title | Enhancement of chemotherapy by manipulation of tumour pH |
title_full | Enhancement of chemotherapy by manipulation of tumour pH |
title_fullStr | Enhancement of chemotherapy by manipulation of tumour pH |
title_full_unstemmed | Enhancement of chemotherapy by manipulation of tumour pH |
title_short | Enhancement of chemotherapy by manipulation of tumour pH |
title_sort | enhancement of chemotherapy by manipulation of tumour ph |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363059/ https://www.ncbi.nlm.nih.gov/pubmed/10362108 http://dx.doi.org/10.1038/sj.bjc.6690455 |
work_keys_str_mv | AT raghunandn enhancementofchemotherapybymanipulationoftumourph AT hex enhancementofchemotherapybymanipulationoftumourph AT sluisrvan enhancementofchemotherapybymanipulationoftumourph AT mahoneyb enhancementofchemotherapybymanipulationoftumourph AT baggettb enhancementofchemotherapybymanipulationoftumourph AT taylorcw enhancementofchemotherapybymanipulationoftumourph AT painemurrietag enhancementofchemotherapybymanipulationoftumourph AT roed enhancementofchemotherapybymanipulationoftumourph AT bhujwallazm enhancementofchemotherapybymanipulationoftumourph AT gilliesrj enhancementofchemotherapybymanipulationoftumourph |